Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on October 28, 2005, to report its financial results for the third quarter of 2005. The filing primarily serves to inform investors about the company's performance during the quarter and references a press release containing the detailed financial outcomes. While the 8-K itself does not contain the specific financial figures, it directs investors to the furnished press release (Exhibit 99.1) and supplemental information on the company's website (Exhibit 99.2) for a comprehensive understanding of their third-quarter results. Investors should consult these referenced documents for details on revenue, earnings, and any other significant financial and operational metrics for the period.
Key Highlights
- 1BMY filed an 8-K on October 28, 2005.
- 2The report pertains to the company's financial results for the third quarter of 2005.
- 3The specific financial details are provided in an accompanying press release (Exhibit 99.1).
- 4Additional supplemental information is available on the company's website (Exhibit 99.2).
- 5The filing includes standard corporate information such as the company's address and phone number.
- 6The report is signed by Sandra Leung, Secretary, indicating official company action.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially report Bristol-Myers Squibb Company's financial results for the third quarter of 2005 to the public and the SEC.
The actual financial results are detailed in the press release filed as Exhibit 99.1 to this 8-K. Supplemental information, not included in the press release, is also available on the company's website at www.bms.com as Exhibit 99.2.
No, this 8-K filing itself does not contain the specific financial numbers. It serves as a notification that the results have been released and directs investors to the referenced exhibits (press release and website supplemental information) for those details.
The filing includes standard corporate details such as the company's legal name, incorporation jurisdiction, principal executive office address, and telephone number. It also includes the signature of the company's Secretary, confirming the filing's authenticity.